Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14962633 | 0.89 | USP2 (0.56) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL373637 | 0.86 | USP2 (0.58) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL5854880 | 0.84 | USP2 (0.55) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL1106391 | 0.84 | USP2 (0.51) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL9715030 | 0.83 | USP2 (0.55) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL30514021 | 0.83 | USP2 (0.55) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL14089863 | 0.81 | USP2 (0.53) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL16588236 | 0.81 | USP2 (0.53) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL25638703 | 0.81 | USP2 (0.53) | USP2HTTPLA2G2CHSD17B10LPAR5 | |
| SCHEMBL373857 | 0.80 | USP2 (0.51) | USP2HTTPLA2G2CHSD17B10LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100288963-A1 | Modified silica particles and dirt repellent polymer compositions comprising them | BASF SE (DE) | 2010-11-18 | — | — | US | disclosed |
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | disclosed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RFC1, RFC2, HNRNPC | USP2 4786/4885HTT 1251/4885PLA2G2C 14/4885 |
| US-20100288963-A1 | Modified silica particles and dirt repellent polymer compositions comprising them | ITCH, DSTN, CD44 | USP2 1225/4885HTT 1865/4885PLA2G2C 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.